Dkk-1 Activators
Common Dkk-1 Activators include, but are not limited to Dexamethasone CAS 50-02-2, PGE2 CAS 363-24-6, D(+)Glucose, Anhydrous CAS 50-99-7, Cholecalciferol CAS 67-97-0 and Retinoic Acid, all trans CAS 302-79-4.
The chemical class known as Dkk-1 activators pertains to compounds or molecules that modulate the activity of Dickkopf-1 (Dkk-1), which is a key player in the Wnt signaling pathway. The Wnt pathway is a highly conserved signaling cascade that plays a fundamental role in embryonic development, tissue homeostasis, and various cellular processes, including cell proliferation, differentiation, and migration. Dkk-1 is a secreted glycoprotein that negatively regulates the Wnt signaling pathway by binding to and inhibiting the Wnt co-receptor LRP5/6, thereby blocking the activation of downstream signaling events.
Dkk-1 activators are of significant interest to researchers studying the complex regulation of the Wnt pathway. These activators may include small molecules or compounds that enhance the expression or function of Dkk-1 or its binding to LRP5/6, ultimately resulting in the inhibition of Wnt signaling. By modulating the activity of Dkk-1, researchers can gain insights into the intricate molecular mechanisms that govern the Wnt pathway's activity and its roles in various physiological and pathological processes. Understanding the function of Dkk-1 and its regulation is critical for advancing our knowledge of developmental biology, tissue regeneration, and the progression of diseases such as cancer, where dysregulation of Wnt signaling is often observed. In summary, Dkk-1 activators serve as essential tools for elucidating the complexities of the Wnt signaling pathway and its impact on a wide range of biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids, such as Dexamethasone, are known to induce DKK-1 expression, especially in osteoblasts. This induction is thought to be one of the mechanisms by which prolonged glucocorticoid therapy can lead to osteoporosis or bone loss. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2, a lipid mediator in inflammatory processes, has been shown to induce DKK-1 expression in some studies. However, its effect on DKK-1 might be context-dependent, varying based on the cell type and specific conditions. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
In the context of diabetes, high glucose levels can stimulate DKK-1 expression in various cell types, potentially contributing to complications like vascular issues or impaired bone healing. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
In certain contexts, Vitamin D and its analogs can stimulate DKK-1 expression. This induction is especially noted in cancer cells, where DKK-1 might play roles in tumor growth or metastasis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a metabolite of Vitamin A, retinoic acid can induce DKK-1 expression, especially during processes like cellular differentiation or development. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Some bioactive lipids, like LPA, have been associated with the induction of DKK-1, especially in the context of cancer cell signaling and tumor microenvironment interactions. | ||||||